Literature DB >> 9919981

The use of microemulsion electrokinetic chromatography in pharmaceutical analysis.

M F Miola1, M J Snowden, K D Altria.   

Abstract

The use of a single set of microemulsion electrokinetic chromatography (MEEKC) separation conditions has been assessed for its applicability in the analysis of a range of pharmaceutical compounds. Particular emphasis was placed on neutral or very hydrophobic compounds, which can be difficult to analyse by conventional capillary electrophoresis. The microemulsion employed for the majority of separations consisted of 0.81% w/w octane, 6.61% w/w 1-butanol, 3.31% w/w sodium dodecyl sulphate and 89.27% w/w 10 mM sodium tetraborate buffer. Good separations of methyl, ethyl, butyl and propyl hydroxybenzoates, and a range of ionic and neutral water soluble and insoluble compounds was achieved using a single set of separation conditions. A number of novel applications of MEEKC were developed included the simultaneous determination of the active components and preservatives in liquid formulation and determination of drug related impurities. Improved performance was obtained through use of internal standards and preparation of the samples dissolved in the microemulsion solution. Validation aspects such as linearity, repeatability, accuracy, injection precision and sensitivity were successfully assessed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9919981     DOI: 10.1016/s0731-7085(98)00217-9

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  A Screening Method for P450 BM3 Mutant Libraries Using Multiplexed Capillary Electrophoresis for Detection of Enzymatically Converted Compounds.

Authors:  Anna Gärtner; Gustavo de Almeida Santos; Anna Joëlle Ruff; Ulrich Schwaneberg
Journal:  Methods Mol Biol       Date:  2022

2.  Determination of artemether and lumefantrine in anti-malarial fixed-dose combination tablets by microemulsion electrokinetic chromatography with short-end injection procedure.

Authors:  N'Cho Christophe Amin; Huguette Fabre; Marie-Dominique Blanchin; Jérôme Montels; Michèle Aké
Journal:  Malar J       Date:  2013-06-13       Impact factor: 2.979

3.  A 96-multiplex capillary electrophoresis screening platform for product based evolution of P450 BM3.

Authors:  Anna Gärtner; Anna Joëlle Ruff; Ulrich Schwaneberg
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.